The human major histocompatibility complex (MHC) class I allele HLA-B27 bea
rs a striking association with the spondylolarthritic group of inflammatory
arthritides, yet despite extensive studies its role in the disease process
remains obscure. As an MHC class I protein, the primary function of HLA-B2
7 is to complex with beta(2)-microglobulin forming a structure that present
s short antigenic peptides for recognition by cytotoxic T lymphocytes (CTL)
. It has been proposed that the role of HLA-B27 in spondyloarthropathy invo
lves this process of antigen presentation, and of the numerous theories pro
posed to explain the association, the most popular have involved the bindin
g and presentation of "arthritogenic" peptides. Transgenic rodent studies d
irectly implicate HLA-B27 heavy chains in disease pathogenesis, but suggest
that the mechanism may be distinct from their primary function. The recent
demonstration that HLA-B27 heavy chains can form stable homodimers may thu
s be of relevance. This review summarizes the evidence supporting current t
heories of disease association and proposes an alternative model of disease
based on recent findings.